- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07943442
Novel MRI for an Earlier Diagnosis of Motor Neurone Disease (MRF MND)
The goal of the study is Can MR Fingerprinting identify quantitative differences in brains of patients with MND and age-matched healthy controls?
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
The Investigators will recruit consecutive patients with MND, identified via the Leeds MND clinic.
Patients will be provided with a patient information sheet (PIS) when they attend the clinic and will have the opportunity to discuss the study with a clinician and ask questions.
If they are willing and able to provide informed consent at this time, consent will be taken, and the participant will be reassured they may withdraw at any time. If the patient wishes time to consider the study, with their permission, they will be contacted via telephone after 24 hours and asked whether or not they wish to be included, again reassured they may withdraw at any time.
An email inviting individuals aged 18 or over to undergo MR imaging of the brain will be distributed throughout Leeds Teaching Hospitals Trust. Those interested will be asked to send their contact details via e-mail reply to the Department of Neuroradiology.
Potential participants will be contacted by a member of the research team and will be taken through a pre-prepared questionnaire detailing present and past medical history. Individuals that answer negatively for the presence of chronic or current illness, particularly regarding neurological disease or psychiatric conditions and that are free from medication and that satisfy MR safety regulations (i.e. no cardiac pacemakers or metallic implants) will be provided with an MRI appointment. All participants will be sent (via email and at least 24 hours prior to the MRI appointment) a PIS. Informed consent will be obtained on arrival for their MRI appointment by a member of the research team.
A consultant neuroradiologist will review all imaging for both cohorts. Any incidental pathology discovered on the MRI requiring medical review will be recorded as a 'Foreign Films for Opinion' on the the Leeds Teaching Hospitals Trust radiology information system and will be alerted to the volunteers' GP, reflecting pre-existing practice within Leeds Teaching Hospitals Trust for research imaging studies.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Stuart Currie
- Telefonnummer: +44 01133923180
- E-Mail: stuartcurrie@nhs.net
Studienorte
-
-
West Yorkshire
-
Leeds, West Yorkshire, Vereinigtes Königreich, LS9 7TF
- Rekrutierung
- Leeds Teaching Hospitals NHS Trust
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
The target population will be patients with MND attending the MND clinic, Leeds Teaching Hospitals Trust and healthy volunteers of workers or relatives of workers within Leeds Teaching Hospitals Trust.
Although MND (ALS) can strike at any age, symptoms most commonly develop between the ages of 55 and 75. Men are slightly more likely to develop ALS than women. However, at older ages, men and women are equally likely to be diagnosed with ALS. Whites and non-Hispanics are most likely to develop the disease, but ALS affects people of all races and ethnic backgrounds.
Beschreibung
Inclusion criteria all participants:
- ≥18yrs
- Able and willing to provide consent
- Able to communicate with staff and safely comply with the study procedures
Additional inclusion criteria for MND participants:
- ALS patients with definite or probable motor neuron disease based on the Awaji criteria
Additional inclusion criteria for healthy volunteers:
- Free from chronic or current illness particularly:
- Neurological disorders including migraines
- Psychiatric disorders
- Prior head injury resulting in brain damage
- Prior neurosurgical or neurovascular intervention
- Free from taking medication
- Non-drug and non-alcohol abuse
- Non-smoker
Exclusion criteria all participants:
-
Contraindication to MRI, including:
- non-MRI compatible medical devices and implants
- in patients with previous penetrating trauma to the eye, or patients at high risk of previous metal foreign body injury to the eye (e.g. welding), skull x-ray will be performed; these patients may be included in the absence of residual metal fragments on x-ray
- Inability to lie flat in the MRI scanner
- ALS patients in an advanced disease stage (ALSFRS-R < 25) with respiratory insufficiency (forced vital capacity (FVC) < 60%), on non-invasive ventilation or receiving percutaneous gastrostomy feeding.
-
Pregnant
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: CASE_CONTROL
- Zeitperspektiven: PROSPECTIVE
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
MND Patients
MND |
MRI of the brain including MRF |
|
Healthy Volunteers
Healthy volunteers of workers or relatives of workers within Leeds Teaching Hospitals Trust |
MRI of the brain including MRF |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Quantitative values of brain cortical regions on MRF
Zeitfenster: Scan time of less than 60 minutes
|
Both cohorts will undergo the same MRI protocol comprising routine clinical structural imaging of the brain and MRF; with a scan time of less than 60 minutes. All images from both cohorts will be reviewed by a consultant neuroradiologist. Should there be any unexpected findings, the volunteers' GP will be informed in writing. After the scan, the volunteers from both cohorts will be free to leave, at which point their direct participation in the study will concluded. |
Scan time of less than 60 minutes
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Erkrankungen des zentralen Nervensystems
- Erkrankungen des Nervensystems
- Neuromuskuläre Erkrankungen
- Stoffwechselerkrankungen
- Neurodegenerative Krankheiten
- Erkrankungen des Rückenmarks
- TDP-43 Proteinopathien
- Proteostase-Mängel
- Motoneuron-Krankheit
- Ernährungs- und Stoffwechselerkrankungen
- Amyotrophe Lateralsklerose
Andere Studien-ID-Nummern
- NE25/181701
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .